Impact Biomedical Inc. held its annual meeting of stockholders on November 5, 2025. During the meeting, stockholders approved the election of Frank D. Heuszel, Elise Brownell, Melissa Sims, Castel Hibbert, David Keene, Christian Zimmerman, Jason Grady, and Chan Heng Fai Ambrose to the board of directors. The appointment of Grassi & Co. Certified Public Accountants, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was also ratified.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-021066), on November 06, 2025, and is solely responsible for the information contained therein.